AMENDED: NOTICE OF FULL YEAR RESULTS

RNS Number : 7137S
Impact Healthcare REIT PLC
18 March 2021
 

 

 

 

The following amendment has been made to the 'NOTICE OF FULL YEAR RESULTS' announcement released on 18 March 2021 at 07:00 under RNS No 6319S

 

The Company will release its annual results for the 12 months ended 31 December 2020.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

18 March 2021

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

NOTICE OF FULL YEAR RESULTS

Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes,   will announce its annual results for the 12 months ended 31 December 2020 on Monday, 29 March 2021.

 

A Company presentation for investors and analysts will take place via a webcast and conference call at 9.00am (UK) on the day .

 

For those who wish to access the live webcast, please register here:

https://www.investis-live.com/impact-reit/6051c96e9a1388100054587d/fwle

 

For those who wish to access the live conference call, please contact Maitland/AMO at impacthealth-maitland@maitland.co.uk   or by telephone on +44 (0) 20 7379 5151.

 

The recording of the presentation will also be made available later in the day via the Company website: https://www.impactreit.uk/investors/reporting-centre/presentations/

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

via Maitland/AMO

 

 

Winterflood Securities Limited

Joe Winkley

Neil Langford

020 3100 0000

 

 

RBC Capital Markets

Rupert Walford

Matthew Coakes

020 7653 4000

 

 

Maitland/AMO (Communications Adviser)

James Benjamin

07747 113 930

impacthealth-maitland@maitland.co.uk

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT is available at www.impactreit.uk .

 

NOTES:

Impact Healthcare REIT plc is a real estate investment trust ("REIT") which aims to provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of UK healthcare real estate opportunities, in particular care homes for the elderly. The Group's investment policy is to acquire, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full repairing and insuring leases.

 

The Company has a progressive dividend policy with a target to grow its annual aggregate dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group's leases in the prior financial year.

 

On this basis, t he target total dividend for the year ending 31 December 2021 is 6.41 pence per share*, a 1.91% increase over the 6.29 pence in dividends paid or declared per ordinary share for FY 2020.

 

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.

 

*  This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORSFMSUAEFSEDD
UK 100